System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Guillaume Chaby is an expert in Dermatology at Centre Hospitalier Universitaire Amiens-Picardie (France). Guillaume Chaby has authored 281 publications, the most recent in 2026, and is an investigator in 16 clinical trials, 5 of them ongoing. SLR score: 874 (community average: 125). How the SLR is computed.

LeadR Profile

Guillaume Chaby Centre Hospitalier Universitaire Amiens-Picardie France
874 ScienceLeadR Reputation 874

Unlock

Register Login
Network Map

Dermatology

Subspecialties: Infectiology - Immunology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2005 - 2026
Source: PubMed

Centre Hospitalier Universitaire Amiens-Picardie

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 281

Citations

Citations: 3 555 1st author: 15 Last author: 54 Unique author: 1

Main journals

Ann Dermatol Venereol 108
Annales de Dermatologie et de Vénéréologie - FMC 21
Annales de dermatologie et de vénéréologie, FMC 17
Br J Dermatol 15
J Eur Acad Dermatol Venereol 13

Best Journals

J Clin Oncol 1
Lancet 1
N Engl J Med 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Terra Firma-Forme Dermatosis or Dermatosis Neglecta: A Diagnostic Continuum Illustrated by a Pediatric Case of Post-circumcision Penile Allodynia.
PMID 42877474 — skin, circumcision, male, autism spectrum disorder, pain, caregivers, skin diseases, neglecta, keratins		Cureus20260
Correction: Effectiveness and Safety of IL‑17A Inhibitors in Pediatric Psoriasis: A Real‑World, Multicenter, International Study.
PMID 42870136 — safety, pharmaceutical preparations, psoriasis		Paediatr Drugs20260
Leg-type diffuse large-cell lymphoma of the nasal area treated with contact radiotherapy.
PMID 42522527 — radiotherapy, cells, lymphoma, lymphoma, large b-cell, diffuse		Dermatol Online J20260
Management of erythromelalgia: A retrospective multicenter study.
PMID 42470997 — sexually transmitted diseases, erythromelalgia, dermatology		Ann Dermatol Venereol20260
Comment on: « Skin cancer risk in patients with non-dermatologic immune-mediated inflammatory diseases" by Letarouilly et al. Joint Bone Spine. 2026;93: 105972.
PMID 42431589 — skin, neoplasms, skin neoplasms, spine		Joint Bone Spine20260

Clinical Studies 16

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

Phase 3 9
N/A 3
Phase 4 3
Phase 2 1

By status:

Completed 7
Recruiting 3
Unknown 3
Active not recruiting 2
Not yet recruiting 1

By type:

Interventional 13
Observational 3

By Monocentric/Multicentric:

monocentric 6
multicentric2to4 1
multicentric5to9 0
multicentricup10 9

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents with Moderate to Severe Atopic Dermatitis
2023-508235-31-00 — safety, dermatitis, signs and symptoms, adolescent, therapeutics, dermatitis, atopic		Phase 3Active not recruiting2024
Phase 2 Proof of Concept Study of LAD328 in Adults with Hidradenitis Suppurativa
2025-521865-29-00 — safety, hidradenitis suppurativa, proof of concept study, hidradenitis		Phase 2Recruiting2026
Prophylaxis of Recurrent Erysipelas in Lower Limbs compreSsion thErapy vs aNTibiotics and Compression Therapy
NCT07549594 — nurses, research design, cellulitis, telemedicine, emollients, erysipelas, penicillin v, therapeutics, random allocation, infections, stockings, compression, male		Phase 4Not yet recruiting2026
Comparison of a Personalized Maintenance Therapy With the Standard Treatment in Pemphigus
NCT05898308 — injections, skin, antibodies, adrenal cortex hormones, skin diseases, desmogleins, biomarkers, maintenance, rituximab, precision medicine, acantholysis, therapeutics, pemphigus		Phase 4Recruiting2024
Randomized Double Blind Controlled Trial Comparing the Safety and Efficacy of Apremilast Versus Placebo in Severe Forms of Recurrent Aphthous Stomatitis
NCT04227314 — stomatitis, aphthous, safety, tablets, stomatitis, therapeutics		Phase 3Recruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS